Global Neurosurgery Devices Market Size Study & Forecast, by Product (Neuromodulation, Neuroendoscopy) and Application (Chronic Pain, Depression, Parkinson’s, Ischemia, Transnasal Neuroendoscopy) and Regional Forecasts 2022-2032

Global Neurosurgery Devices Market is valued at approximately USD 13.5 billion in 2024 and is projected to expand at a robust CAGR of 13.00% over the forecast period 2025-2035. Neurosurgery devices encompass a wide array of instruments and equipment designed to aid in complex neurological procedures, ranging from minimally invasive surgeries to advanced neuromodulation therapies. These devices are critical in improving patient outcomes, enhancing surgical precision, and reducing recovery time. The market growth is largely fueled by rising prevalence of neurological disorders, increasing adoption of technologically advanced surgical solutions, and continuous investments in research and development across the globe.

The escalating incidence of chronic neurological conditions such as Parkinson’s disease, chronic pain syndromes, depression, and ischemic disorders has significantly bolstered the demand for neurosurgical interventions. According to WHO data, neurological disorders affect more than one billion individuals worldwide, emphasizing the urgent need for effective treatment solutions. Additionally, advancements in neuromodulation devices, including spinal cord stimulation and deep brain stimulation, coupled with the growing adoption of neuroendoscopic procedures, have created new avenues for the market. However, stringent regulatory frameworks and high costs of advanced neurosurgery devices could pose challenges to market expansion during the forecast period.

From a regional perspective, North America dominated the global Neurosurgery Devices Market in 2025, driven by a well-established healthcare infrastructure, high healthcare expenditure, and extensive adoption of advanced neurosurgical technologies. The U.S., in particular, remains a significant contributor due to robust research initiatives and rising demand for minimally invasive neurosurgical solutions. Europe also accounts for a substantial market share, with Germany, France, and the UK leading in technological adoption and healthcare service expansion. The Asia Pacific region is projected to witness the fastest growth during 2025-2035, fueled by rapid urbanization, growing healthcare investments, increasing prevalence of neurological disorders, and rising awareness about advanced treatment options in countries such as China, India, and Japan. Latin America and the Middle East & Africa are gradually emerging as lucrative markets due to expanding healthcare infrastructure and government initiatives supporting medical device adoption.

Major market players included in this report are:
• Medtronic Plc
• Boston Scientific Corporation
• Stryker Corporation
• Abbott Laboratories
• Johnson & Johnson
• TheraCell Neuroscience
• Globus Medical Inc.
• Zimmer Biomet Holdings Inc.
• Baxter International Inc.
• NuVasive Inc.
• Integra LifeSciences Corporation
• Boston Scientific Neuromodulation Division
• Cyberonics, Inc.
• Fresenius Medical Care AG & Co. KGaA
• Neuronetics Inc.

Global Neurosurgery Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation)
• Neuroendoscopy

By Application:
• Chronic Pain
• Depression
• Parkinson’s
• Ischemia
• Transnasal Neuroendoscopy

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of APAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035
• Annualized revenues and regional level analysis for each market segment
• Detailed analysis of geographical landscape with Country level analysis of major regions
• Competitive landscape with information on major players in the market
• Analysis of key business strategies and recommendations on future market approach
• Analysis of competitive structure of the market
• Demand side and supply side analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more